These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9051146)

  • 1. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
    Zaccheo T; Giudici D; di Salle E
    Prostate; 1997 Feb; 30(2):85-91. PubMed ID: 9051146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats.
    Zaccheo T; Giudici D; di Salle E
    Prostate; 1998 Jun; 35(4):237-42. PubMed ID: 9609545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat.
    di Salle E; Giudici D; Briatico G; Ornati G; Panzeri A
    J Steroid Biochem Mol Biol; 1993 Nov; 46(5):549-55. PubMed ID: 8240976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen flutamide on the Dunning R3327 prostatic carcinoma in rats.
    Zaccheo T; Giudici D; di Salle E
    Endocr Relat Cancer; 1999 Sep; 6(3):429-35. PubMed ID: 10516856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination effect of flutamide and leuprorelin acetate on growth of Dunning R3327-H prostatic adenocarcinoma in rats].
    Tomura A; Kuroiwa S; Okada M; Abe F
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):563-9. PubMed ID: 9530363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
    Imada S; Akaza H; Ami Y; Koiso K; Ideyama Y; Takenaka T
    Eur Urol; 1997; 31(3):360-4. PubMed ID: 9129932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the dual 5alpha-reductase inhibitor PNU 157706 on the growth of dunning R3327 prostatic carcinoma in the rat.
    Zaccheo T; Giudici D; di Salle E
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):193-8. PubMed ID: 9605414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
    Zaccheo T; Giudici D; Panzeri A; di Salle E
    Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
    Di Salle E; Briatico G; Giudici D; Ornati G; Panzeri A
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of Dunning R3327 rat prostatic tumor with the 5alpha-reductase inhibitor PNU 157706 and the antiandrogen bicalutamide.
    Zaccheo T; Giudici D; Panzeri A; di Salle E
    Cancer Chemother Pharmacol; 2000; 45(1):31-7. PubMed ID: 10647498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland. International Prostate Health Council (IPHC) Trial Study Group.
    Kirby R; Robertson C; Turkes A; Griffiths K; Denis LJ; Boyle P; Altwein J; Schröder F
    Prostate; 1999 Jul; 40(2):105-14. PubMed ID: 10386471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
    Brooks JR; Berman C; Nguyen H; Prahalada S; Primka RL; Rasmusson GH; Slater EE
    Prostate; 1991; 18(3):215-27. PubMed ID: 1850515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early exposure of flutamide on subsequent growth of transplantable rat prostatic tumor (dunning R-3327).
    Lee SZ; Sato N; Suzuki H; Watabe Y; Masai M; Shimazaki J
    Prostate; 1994 Apr; 24(4):197-203. PubMed ID: 8146068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitory effect of TZP-4238 on the growth of androgen-sensitive rat prostatic tumor (Dunning R3327).
    Ichikawa T; Akimoto S; Shimazaki J
    Endocr J; 1993 Aug; 40(4):425-30. PubMed ID: 7522799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model.
    Redding TW; Schally AV
    Prostate; 1985; 6(3):219-32. PubMed ID: 3157927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
    Yano T; Pinski J; Szepeshazi K; Milovanovic SR; Groot K; Schally AV
    Prostate; 1992; 20(4):297-310. PubMed ID: 1351672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
    Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adrenalectomy, flutamide, and leuprolide on the growth of the Dunning rat R-3327 prostatic carcinoma.
    Kung TT; Mingo GG; Siegel MI; Watnick AS
    Prostate; 1988; 12(4):357-63. PubMed ID: 3134647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.